Jassin, M., Onkelinx, C., Bocuzzi, V., E Silva, B., Kwan, O., Block, A., Dubois, S., Daulne, C., Marcion, G., Ormenese, S., Di Valentin, E., Baron, F., GREGOIRE, C., Ehx, G., Nguyen, T. T., & Caers, J. (08 December 2025). Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma. Cells, 14 (24), 1944. doi:10.3390/cells14241944 |
Bocuzzi, V., Bridoux, J., PIROTTE, M., Withofs, N., Hustinx, R., D'Huyvetter, M., Caers, J., & Marcion, G. (2024). Correction to: CD38 as theranostic target in oncology (Journal of Translational Medicine, (2024), 22, 1, (998), 10.1186/s12967-024-05768-6). Journal of Translational Medicine, 22 (1), 1113. doi:10.1186/s12967-024-05959-1 |
Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E., & D'Huyvetter, M. (2022). Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology, 13, 911080. doi:10.3389/fimmu.2022.911080 |